Eli Lilly’s new Prozac Fact Sheet (image below) sent to UK physicians–but not to US physicians–states that Prozac is NOT RECOMMENDED FOR CHILDREN for any indication. For a larger view, please click on the image.
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies.
A forceful editorial by the St. Petersburg Times cuts through the Bull: "There is altogether too much secrecy in court cases that implicate public health."
“Lilly is Hiding Negative Information About Zyprexa” – SAPS Wed, 2 Nov 2005 From our colleague in Sweden: A published interview with Dr. Curt Furberg, Professor of Public Health Sciences Wake Forest University Baptist Medical Center, and Chair, Steering Committee, and Principal Investigator, of one of the most important studies…
NYS AG Expands Pharmaceutical probe – Forest Labs Wed, 30 Jun 2004 The New York Times reports (below) that New York State Attorney General, Eliot Spitzer, is broadening his legal investigation. “Mr. Spitzer said in a speech on Monday to health care lawyers that he would continue to investigate how…
EPA Nominee Challenged in Senate Over Children’s Pesticide Experiment Thu, 07 Apr 2005 AHRP applauds Senator Barbara Boxer for pledging to hold up the confirmation of Stephen Johnson, the President’s nominee to head the Environmental Protection Agency, until he pulls the plug on “the appalling, unethical, and immoral” children’s pesticide…
